Permira is frontrunner to acquire $150-200M stake in Cloudnine Hospitals from True North, edging out TPG. Deal downsized after West Asia acquisition dropped.
Alpha Score of 53 reflects moderate overall profile with weak momentum, moderate value, moderate quality, moderate sentiment.
Global private equity firm Permira is the frontrunner to buy a $150-200 million stake in Cloudnine Hospitals, two people familiar with the matter said, edging out TPG in a deal that would mark one of the firm's earliest direct investments in India.
Permira moved faster through due diligence and is likely to close the transaction, one of the people said. The stake sale is secondary, with existing investor True North selling its holdings after more than a decade. The round has been downsized from an earlier plan to raise $250-300 million, which was meant to fund an acquisition in West Asia, the second person added. That expansion did not proceed.
Permira and TPG declined to comment. Cloudnine and True North did not respond to requests for comment.
Permira entered India earlier this year by taking a 40% stake in real estate services platform SILA for $100 million, Mint reported in April. Siddharth Narayan, the firm's India head, would oversee the Cloudnine investment if it closes.
The deal comes months after Cloudnine's operator, Kids Clinic India Pvt Ltd, agreed to buy the maternity, childcare and fertility businesses of Apollo Health & Lifestyle in a cash-and-stock deal valued at about $160 million. That transaction gave Apollo a 9.9% stake worth ₹785 crore, valuing Cloudnine at roughly ₹7,930 crore ($825 million).
Cloudnine's largest shareholders are private equity funds: True North (first invested in 2015), Temasek (2024) and TPG NewQuest (2021). Promoters hold a small slice.
Founded in 2006 by R Kishore Kumar, Rohit M.A., M. Ramachandra and Vidya Kumar, Cloudnine runs a chain of single-specialty hospitals focused on mother and baby care. Its services cover fertility, maternity, gynecology, pediatrics, neonatology and stem cell banking. The chain operates roughly 40 centers across 13 cities, including Bengaluru, Delhi, Mumbai, Pune, Chennai and Gurugram.
Cloudnine's operating revenue rose to ₹1,485.6 crore in FY25 from ₹1,187.7 crore the prior year, according to a report from credit rating agency Icra. Its loss widened to ₹46.4 crore from ₹27.9 crore. Icra expects healthy revenue growth near term, driven by a ramp-up at existing centers and improving contributions from newer ones.
The company competes with Motherhood Hospitals, Indira IVF, Milann Fertility & Maternity, Rainbow Children's Hospital and large general hospital chains such as Manipal Health Enterprises and Max Healthcare.
India's healthcare provider market is expected to grow more than 10% a year into a $95 billion market by 2030, according to Bessemer Venture Partners. The single-specialty segment alone is projected to expand from $4.4 billion in 2025 to about $12.3 billion over the same period.
TPG, which was also in the running for the Cloudnine stake, carries an Alpha Score of 53 at AlphaScala, a Mixed label within the Financial Services sector.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.